Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP-1001 in Allergic Rhinitis
NCT00791102Phase 3Completed
- Sponsor
- University of Chicago
- Start
- Jan 2010
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ASP-1001 in allergic rhinitis (AR), sponsored by University of Chicago. Started Jan 2010; status: completed.
02
Drugs
ASP-1001
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT00791102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00791102.